News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
HAASER CHARLES B
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/13/2023 |
4
| HAASER CHARLES B (VP Finance and CAO) has filed a Form 4 on YIELD10 BIOSCIENCE, INC.|
Txns:
| Granted 18,000 options to buy
@ $3.15, valued at
$56.7k
|
|
| 08/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| HAASER CHARLES B (VP Fin and CAO) has filed a Form 4 on YIELD10 BIOSCIENCE, INC.|
Txns:
| Granted 5,603 shares
@ $3.83, valued at
$21.5k
Granted 18,000 options to buy
@ $3.83, valued at
$68.9k
|
|
| 12/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2021 |
4
| HAASER CHARLES B (VP Fin & Chief Accting Officer) has filed a Form 4 on YIELD10 BIOSCIENCE, INC.|
Txns:
| Granted 11,500 options to buy
@ $16.49, valued at
$189.6k
|
|
| 08/13/2020 |
4
| HAASER CHARLES B (VP Fin & Chief Accting Officer) has filed a Form 4 on YIELD10 BIOSCIENCE, INC.|
Txns:
| Paid exercise price by delivering 587 shares
@ $6.55, valued at
$3.8k
|
|
| 05/29/2020 |
4
| HAASER CHARLES B (VP Fin & Chief Accting Officer) has filed a Form 4 on YIELD10 BIOSCIENCE, INC.|
Txns:
| Granted 21,000 options to buy
@ $5.86, valued at
$123.1k
|
|
| 02/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2019 |
4
| HAASER CHARLES B (VP Fin & Chief Accting Officer) has filed a Form 4 on YIELD10 BIOSCIENCE, INC.|
Txns:
| Granted 60,000 options to buy
@ $0.9, valued at
$54k
|
|
| 04/03/2019 |
4
| HAASER CHARLES B (VP Fin & Chief Accting Officer) has filed a Form 4 on YIELD10 BIOSCIENCE, INC.|
Txns:
| Paid exercise price by delivering 245 shares
@ $1.16, valued at
$284.2 |
|
| 05/25/2018 |
4
| HAASER CHARLES B (VP Fin & Chief Accting Officer) has filed a Form 4 on YIELD10 BIOSCIENCE, INC.|
Txns:
| Granted 100,000 options to buy
@ $1.65, valued at
$165k
|
|
| 04/04/2017 |
4
| HAASER CHARLES B (VP Fin & Chief Accting Officer) has filed a Form 4 on YIELD10 BIOSCIENCE, INC.|
Txns:
| Paid exercise price by delivering 2,673 shares
@ $0.37, valued at
$989 |
|
| 10/28/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|